Swallowable balloon offers Non-Surgical weight loss hope

NCT ID NCT07684664

Not yet recruiting Disease control Sponsor: Allurion Technologies Source: ClinicalTrials.gov ↗

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This study evaluates the safety and effectiveness of the Allurion Gastric Balloon System, a swallowable balloon placed in the stomach to help with weight loss. It involves 250 adults aged 22–65 with a BMI between 30 and 40. The balloon is swallowed and later passes naturally, avoiding surgery. The main goal is to confirm that serious side effects are rare, while also measuring weight loss at 48 weeks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Allurion Gastric Balloon System (a swallowable gastric balloon)
What this could lead to: If successful, this could confirm a safe, non-surgical weight-loss option for people with obesity.
What could go wrong: This is a post-market study confirming safety, not a new breakthrough. The balloon may cause side effects like nausea or discomfort, and weight loss results vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY & OVERWEIGHT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OBESITY & OVERWEIGHT OBESITY (BMI>30)

More trials for these conditions

Other studies related to the condition(s) this trial covers.